In situ evidence for DNA fragmentation in Huntingtonʼs disease striatum and Alzheimerʼs disease temporal lobes
- 1 May 1995
- journal article
- research article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 6 (7) , 1053-1057
- https://doi.org/10.1097/00001756-199505090-00026
Abstract
To test the hypothesis that apoptosis is involved in human brain neurodegenerative disorders, we investigated whether DNA fragmentation occurs in Alzheimer's disease (AD). Huntington's disease (HD) and Parkinson's disease, as well as in temporal lobe epilepsy, using neurologically normal post-mortem human brain tissue as a control. Using in situ end labelling of DNA, we found evidence of DNA fragmentation in cells in temporal cortex and hippocampus from patients with AD and in striatum from those with HD. In contrast, only scattered DNA fragmentation positive cells were detected in the pial surfaces of some of the neurologically normal human brains. Thus, cells in the HD striatum and AD temporal cortex exhibited DNA fragmentation, suggesting that apoptosis may be involved in these disordersKeywords
This publication has 5 references indexed in Scilit:
- Increased Immunoreactivity for Jun- and Fos-Related Proteins in Alzheimer's Disease: Association with PathologyExperimental Neurology, 1994
- Analysis of cell cycle-related gene expression in postmitotic neurons: Selective induction of cyclin D1 during programmed cell deathNeuron, 1994
- Apoptosis in C3H/10T1/2 mouse embryonic cells: evidence for internucleosomal DNA modification in the absence of double-strand cleavage.Proceedings of the National Academy of Sciences, 1993
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue KineticsBritish Journal of Cancer, 1972